China Resources Medical Holdings Company Limited(referred as"CR Medical") is a comprehensive medical listed company. It is the only listing platform of CR Healthcare, which is a wholly owned subsidiary of CR. It has 146 medical institutions, and a total of 21,985 operating beds. Its business covered 10 provinces (regions, cities) .

By means of“M & a-integration-injection”, CR Medical steadily expanded the distribution of medical service network and improved the effect of regional medical resources integration. In 2022, CR Medical acquired 33 high-quality medical institutions and increased the number of open beds by 11,130. The medical service capacity was further strengthened and the profit contribution was significantly increased. The comprehensive strength of the listed company was constantly growing, and long-term value is steadily rising.

CR medical has gave full play to the advantages of group operation and fine management to create a medical operating model with CR characteristics. Taking the construction of regional leading hospitals and regional medical consortia as the carrier, CR Medical has continuously improved its medical institutions' disciplinary construction level,  service quality and intelligence construction ability to provide the public with high-quality and accessible services, and continuously meet the increasing demand of the people for multi-level and diversified medical and health services.

CR Medical drives high-quality development with ESG concept. It improves the management structure, improves the management level, and strengthens the information disclosure to assist the construction of valuation system of listed medical companies with Chinese characteristics. For two consecutive years, the company was selected as“Central enterprise ESG · Pioneer 50 series index”, and the performance case“China Resources Medical Patient Service system construction obvious effect” was selected as“Central enterprise ESG excellent case” in 2022. In 2023, it has been included in the leading ESG Index of central government-owned enterprises on the Hang Seng Hong Kong Stock Connect. The company's market recognition and reputation continues to improve.

Looking to the future, CR Healthcare will bear in mind its corporate mission of Caring for the health of people , and carries out the“Healthy China” strategy. It will strive to build a leading domestic medical and health industry group. It will build a great health full value ecosystem. It will improve the quality of medical care and service level to benefit patients and society.